[Federal Register Volume 80, Number 221 (Tuesday, November 17, 2015)]
[Notices]
[Pages 71804-71806]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29273]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-16-0964]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or
[[Page 71805]]
by fax to (202) 395-5806. Written comments should be received within 30
days of this notice.
Proposed Project
Interventions to Reduce Shoulder MSDS in Overhead Assembly (OMB No.
0920-0964 Exp. 04/30/2015)--Reinstatement--National Institute for
Occupational Safety and Health (NIOSH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The mission of the National Institute for Occupational Safety and
Health (NIOSH) is to promote safety and health at work for all people
through research and prevention. Under Public Law 91- 596, sections 20
and 22 (Section 20-22, Occupational Safety and Health Act of 1970),
NIOSH has the responsibility to conduct research to advance the health
and safety of workers. In this capacity, NIOSH proposes to conduct a
study to assess the effectiveness and cost-benefit of occupational
safety and health (OSH) interventions to prevent musculoskeletal
disorders (MSDs) among workers in the Manufacturing (MNF) sector.
A reinstatement is necessary because there were significant delays
in implementing the tooling intervention in the intended work
processes. These delays were to a large degree due to business
conditions and were outside of the control of investigators. As result,
the study achieved approximately 50% of the original sample size
approved by OMB in the original ICR request. The reinstatement is
necessary to extend the duration of the ICR so that the additional
participants can enrolled and data collection can continue.
The U.S. Manufacturing sector has faced a number of challenges
including an overall decline in jobs, an aging workforce, and changes
in organizational management systems. Studies have indicated that the
average age of industrial workers is increasing and that older workers
may differ from younger workers in work capacity, injury risk, severity
of injuries, and speed of recovery (Kenny et al., 2008; Gall et al.,
2004; Restrepo et al., 2006). As the average age of the industrial
population increases and newer systems of work organization (such as
lean manufacturing) are changing the nature of labor-intensive work,
prevention of MSDs will be more critical to protecting older workers
and maintaining productivity.
This study will evaluate the efficacy of two intervention
strategies for reducing musculoskeletal symptoms and pain in the
shoulder attributable to overhead assembly work in automotive
manufacturing. These interventions are, (1) an articulating spring-
tensioned tool support device that unloads from the worker the weight
of the tool that would otherwise be manually supported, and, (2) a
targeted exercise program intended to increase individual employees'
strength and endurance in the shoulder and upper arm stabilizing muscle
group. As a primary prevention strategy, the tool support engineering
control approach is preferred; however, a cost-efficient opportunity
exists to concurrently evaluate the efficacy of a preventive exercise
program intervention. Both of these intervention approaches have been
used in the Manufacturing sector, and preliminary evidence suggests
that both approaches may have merit. However, high quality evidence
demonstrating their effectiveness, by way of controlled trials, is
lacking. This project will be conducted as a partnership between NIOSH
and Toyota Motors Engineering & Manufacturing North America, Inc.
(TEMA), with the intervention evaluation study taking place at the
Toyota Motor Manufacturing Kentucky, Inc. (TMMK) manufacturing facility
in Georgetown, Kentucky. The prospective intervention evaluation study
will be conducted using a group-randomized controlled trial multi-time
series design. Four groups of 25-30 employees will be established to
test the two intervention treatment conditions (tool support, exercise
program), a combined intervention treatment condition, and a control
condition. The four groups will be comprised of employees working on
two vehicle assembly lines in different parts of the facility, on two
work shifts (first and second shift). Individual randomization to
treatment condition is not feasible, so a group-randomization (by work
unit) will be used to assign the four groups to treatment and control
conditions. Observations will be made over the 24-month study period
and questionnaires will include the Shoulder Rating Questionnaire
(SRQ), Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire,
a Standardized Nordic Questionnaire for body part discomfort, and a
Work Organization Questionnaire. In addition to the questionnaires a
shoulder-specific functional capacity evaluation test battery will be
administered at 90 and 210 days, immediately pre- and post-
intervention, to confirm the efficacy of the targeted exercise program
in improving shoulder capacity.
In summary, this study will evaluate the effectiveness of two
interventions to reduce musculoskeletal symptoms and pain in the
shoulder associated with repetitive overhead work in the manufacturing
industry and the associated research project will disseminate the
results of evidence-based prevention practices to the greatest audience
possible.
There is no cost to respondents other than their time. The
estimated annualized burden is 236 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Employees
Informed Consent Form... 63 1 5/60
Consent of Photographic 63 1 2/60
Image Release.
Physical Activity 63 1 2/60
Readiness (PAR-Q).
Shoulder Rating 63 10 4/60
Questionnaire.
Disabilities of Arm 63 10 6/10
Shoulder and Hand Dash
(DASH).
Standardized Nordic 63 10 4/60
Questionnaire for
Musculoskeletal Symptom
Instruments.
Work Organization 63 3 26/60
Questionnaire.
----------------------------------------------------------------------------------------------------------------
[[Page 71806]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-29273 Filed 11-16-15; 8:45 am]
BILLING CODE 4163-18-P